SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : TAVA Research - No Discussion

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: C.K. Houston who wrote (267)11/15/1997 2:23:00 PM
From: C.K. Houston  Read Replies (1) of 810
 
As general update to company's Y2K activity, John Jenkins, CEO offered the following:

''Our Y2K business opportunity is accelerating faster than our initial expectations.'' Our total engagement count now exceeds 25 clients covering more than 60 sites.

NEW CLIENTS INCLUDE: Company background info provided by CK HOUSTON

Cyprus Amax Minerals
Fastest-growing & largest US-owned mining company. A leading worldwide producer of copper & coal, the world's largest producer of molybdenum & lithium.
cyprusamaxminerals.com

Kennecott Energy
One of the five largest U.S. coal producers. "We stress quality in our mining operations, from computer analysis of our extensive core drilling samples, to sophisticated statistical programs that accurately determine coal quality in advance of our mining operation."
kenergy.com

Unilever Foods North America Assessment & Analysis to be completed THIS month!!)
techstocks.com
Too BIG to write about here, click link

Ivax Pharmaceuticals Assessment & Analysis to be completed by January '98
One of the largest generic drug companies in the world, IVAX is a holding company with subsidiaries involved in generic and brand-name pharmaceuticals, personal care products, and specialty chemicals. It makes more than 100 generic prescription & over-the-counter drugs and distributes another 700. Subsidiary Baker Norton makes brand-name urological medications such as Polycitra-K, a nonsurgical alternative for the treatment of kidney stones.

Among others.....

While many clients are still in the pilot stage, developing cost models for their 1998 budgets others are accelerating dramatically their activity. Unilever Foods has asked us to complete the assessment and analysis phases on their U.S. and Canadian plants before the end of November. A similar engagement with Ivax covers a number of domestic and international operations with a completion target of January 1998.

In the past three weeks, the company has received orders for more than $1,500,000 of PlantY2K One product and services, and expects to close up to another $2,000,000 in the next 30 to 45 days. These orders represent primarily initial inventory and assessment tasks, and include little remediation effort.

SIDEBAR: Conference Call (Jenkins)
["Over the course of the last couple weeks, we have received in excess of $6 million worth of orders in our base business."]

As a raw measure of our activity level, we are in various stages of negotiation with a large number of multi-plant organizations that cover approximately 3000 plant sites. These include both domestic and international operations.

Developing alliance relationships with information technology service companies active in addressing Year 2000 compliance in business systems. This has already led to a number of joint proposals providing clients with full scope Year 2000 service.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext